Leishmania is an obligate intracellular pathogen that invades phagocytic host cells.
Approximately 30 different species of Phlebotomine sand flies can transmit this parasite …

A number of leishmaniasis vaccine candidates are at various stages of pre-clinical and
clinical development. Leishmaniasis is a vector-borne neglected tropical disease (NTD) …

Visceral leishmaniasis (VL), one of the deadliest parasitic diseases in the world, causes
more than 50,000 human deaths each year and afflicts millions of people throughout South …

Leishmaniasis is considered as a zoonotic infection and neglected tropical disease.
Leishmania treatment is not totally successful and imposes high expenditures, especially in …

Currently, there are no commercially available human vaccines against leishmaniasis. In
rodents, cellular immunity to salivary proteins of sand fly vectors is associated to protection …

Leishmaniasis is a vector-borne infectious disease caused by multiple Leishmania (L.)
species with diverse clinical manifestations. There is currently no vaccine against any form …

Parasitic infections are a major global health issue causing significant mortality and
morbidity. Despite substantial advances in the diagnostics and treatment of these diseases …

Visceral leishmaniasis (VL), a vector-borne disease, is caused by an obligate
intramacrophage, kinetoplastid protozoan parasite of the genus Leishmania. Globally, VL is …

Abstract Background Visceral Leishmaniasis (VL) is a fatal vector-borne parasitic disorder
occurring mainly in tropical and subtropical regions. VL falls under the category of neglected …

Canine leishmaniosis is a zoonotic disease caused by Leishmania infantum. Extensive
research is currently ongoing to develop safe and effective vaccines to protect from disease …